ARRY
Price
$7.01
Change
+$0.43 (+6.53%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
2.22B
69 days until earnings call
INO
Price
$2.11
Change
+$0.01 (+0.48%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
77.75M
Interact to see
Advertisement

ARRY vs INO

Header iconARRY vs INO Comparison
Open Charts ARRY vs INOBanner chart's image
Array Technologies
Price$7.01
Change+$0.43 (+6.53%)
Volume$128.83K
Capitalization2.22B
Inovio Pharmaceuticals
Price$2.11
Change+$0.01 (+0.48%)
Volume$3.65K
Capitalization77.75M
ARRY vs INO Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. INO commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and INO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (INO: $2.12)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green while.

  • INO’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while INO’s TA Score has 6 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • INO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INO is a better buy in the short-term than ARRY.

Price Growth

INO (@Biotechnology) experienced а +6.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

INO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than INO($77.7M). INO YTD gains are higher at: 19.101 vs. ARRY (16.060). ARRY has higher annual earnings (EBITDA): 276M vs. INO (-109.89M). ARRY has more cash in the bank: 249M vs. INO (84.8M). INO has less debt than ARRY: INO (12.4M) vs ARRY (730M). ARRY has higher revenues than INO: ARRY (1.58B) vs INO (203K).
ARRYINOARRY / INO
Capitalization2.22B77.7M2,860%
EBITDA276M-109.89M-251%
Gain YTD16.06019.10184%
P/E Ratio26.23N/A-
Revenue1.58B203K776,847%
Total Cash249M84.8M294%
Total Debt730M12.4M5,887%
FUNDAMENTALS RATINGS
ARRY vs INO: Fundamental Ratings
ARRY
INO
OUTLOOK RATING
1..100
1815
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (59) in the Medical Specialties industry is somewhat better than the same rating for ARRY (99) in the Biotechnology industry. This means that INO’s stock grew somewhat faster than ARRY’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

INO's SMR Rating (100) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (42) in the Biotechnology industry is in the same range as INO (64) in the Medical Specialties industry. This means that ARRY’s stock grew similarly to INO’s over the last 12 months.

ARRY's P/E Growth Rating (100) in the Biotechnology industry is in the same range as INO (100) in the Medical Specialties industry. This means that ARRY’s stock grew similarly to INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYINO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 21 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNYA0.490.03
+6.52%
Tenaya Therapeutics
LMB134.971.81
+1.36%
Limbach Holdings
MGPI29.580.37
+1.27%
MGP Ingredients
ABBV187.250.26
+0.14%
ABBVIE
EAT173.36-2.56
-1.46%
Brinker International